Browse
We’re here to help

Find guidance on Author Services

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Therapeutic Patents
List of Issues
Volume 15, Issue 3

Expert Opinion on Therapeutic Patents

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Therapeutic Patents, Volume 15, Issue 3 (2005)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 15, Issue 3 (2005)

See all volumes and issues

Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Volume 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Nanotechnology in the pharmaceutical industry

Paul Chapman

Pages: 249-251

Published online: 22 Apr 2005

AbstractforNanotechnology in the pharmaceutical industry | References | PDF (82.2 KB)

4759 Views
9 CrossRef citations
0Altmetric

Free Access

Review

Review Article

Recent non-hydroxamate matrix metalloproteinase inhibitors

Eli Breuer, Julia Frant & Reuven Reich

Pages: 253-269

Published online: 22 Apr 2005

AbstractforRecent non-hydroxamate matrix metalloproteinase inhibitors | References | PDF (226.6 KB)

109 Views
60 CrossRef citations
0Altmetric

Review Article

Recent progress in the discovery of antagonists acting at P2X₇ receptor

Romeo Romagnoli, Pier Giovanni Baraldi & Francesco Di Virgilio

Pages: 271-287

Published online: 22 Apr 2005

AbstractforRecent progress in the discovery of antagonists acting at P2X₇ receptor | References | PDF (229.6 KB)

78 Views
15 CrossRef citations
0Altmetric

Review Article

11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases

Christopher Fotsch, Ben C Askew & Jian Jeffrey Chen

Pages: 289-303

Published online: 22 Apr 2005

Abstractfor11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases | References | PDF (206.7 KB)

66 Views
41 CrossRef citations
0Altmetric

Miscellaneous

Myriad Genetics

Peter Norman

Pages: 305-309

Published online: 22 Apr 2005

AbstractforMyriad Genetics | References | PDF (113 KB)

22 Views
1 CrossRef citations
0Altmetric

Annotated Patent Selections

Pages: 311-335

Published online: 22 Apr 2005

First Page PreviewforAnnotated Patent Selections | PDF (327.5 KB)

16 Views
0 CrossRef citations
0Altmetric

Inhibitors targeting vascular endothelial growth factor receptor kinases and cyclin-dependent kinases

Pages: 337-341

Published online: 22 Apr 2005

AbstractforInhibitors targeting vascular endothelial growth factor receptor kinases and cyclin-dependent kinases | References | PDF (126.4 KB)

16 Views
0 CrossRef citations
0Altmetric

Novel thiophenecarboxamide IKK-2 inhibitors

Pages: 343-347

Published online: 22 Apr 2005

AbstractforNovel thiophenecarboxamide IKK-2 inhibitors | References | PDF (107.9 KB)

73 Views
3 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

An updated patent review on PD-1/PD-L1 antagonists (2022-present)

Wiktor Uzar et al.

Review Article | Published online: 21 Jun 2024

Protein tyrosine phosphatase inhibitors: a patent review and update (2012–2023)

Lakshmi Mounika Kelam et al.

Review Article | Published online: 19 Jun 2024

A patent review on hypoxia-inducible factor (HIF) modulators (2021–2023)

Jiaming Liu et al.

Review Article | Published online: 19 Jun 2024

Recent advances in the development of P2Y₁₄R inhibitors: a patent and literature review (2018-present)

Kai Wang et al.

Review Article | Published online: 19 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Patents (Vol.15, Iss.3, 2005)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?